Cargando…
Recurrence of 2,8-dihydroxyadenine Crystalline Nephropathy in a Kidney Transplant Recipient: A Case Report and Literature Review
We herein report the case of a kidney transplant patient with recurrence of obstructive nephropathy that was not diagnosed as adenine phosphoribosyltransferase (APRT) deficiency until gene testing identified a pathogenic homozygous variant three years after renal transplantation. Subsequently, the p...
Autores principales: | Cheng, Yamei, Guo, Luying, Wang, Meifang, Chen, Jianghua, Wang, Rending |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429296/ https://www.ncbi.nlm.nih.gov/pubmed/33678741 http://dx.doi.org/10.2169/internalmedicine.6640-20 |
Ejemplares similares
-
Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation
por: Nanmoku, Koji, et al.
Publicado: (2017) -
27558 Obeticholic acid (OCALIVA ®) protects against 2,8-dihydroxyadenine nephropathy in mice
por: Jones, Bryce, et al.
Publicado: (2021) -
Sodium benzoate attenuates 2,8-dihydroxyadenine nephropathy by inhibiting monocyte/macrophage TNF-α expression
por: Oshima, Yoichi, et al.
Publicado: (2023) -
Elevated serum IL-21 levels are associated with stable immune status in kidney transplant recipients and a mouse model of kidney transplantation
por: Guo, Luying, et al.
Publicado: (2020) -
Dihydroxyadenine crystal-induced nephropathy presenting with rapidly progressive renal failure
por: Verma, Ritu, et al.
Publicado: (2018)